News: Allergy Therapeutics Plc (AGY.L)
14.75GBp
18 Dec 2009
0.00p (+0.00%)
14.75p
14.75p
14.75p
14.75p
0
16,980
25.00p
6.00p
Thu, Sep 10 2009
STOCKS NEWS EUROPE-Glaxo vaccine news lifts Allergy shares
Allergy Therapeutics shares gain 3.4 percent, buoyed by news GlaxoSmithKline's cervical cancer vaccine Cervarix, which contains the same adjuvant as Allergy's Pollinex Quattro, has been recommended for approval by U.S. experts.
STOCKS NEWS UK-Glaxo vaccine news lifts Allergy shares
STOCKS NEWS Reuters Results diary
STOCKS NEWS EUROPE-Allergy Therapeutics falls on placing
Shares in hayfever vaccine specialist Allergy Therapeutics tumble 14 percent to 15.3 pence per share after the company announces that it is raising up to 22.4 million pounds through a placing at 12 pence per share.
STOCKS NEWS UK-Allergy Therapeutics falls after placing
STOCKS NEWS Reuters Results diary
STOCKS NEWS EUROPE-Allergy Therapeutics falls on placing
Shares in Allergy Therapeutics tumble 8.7 percent to 15.75 pence after the hayfever vaccine specialist announces that it is raising up to 22.4 million pounds by placing about 163.5 million shares at 12 pence per share.
STOCKS NEWS EUROPE-Allergy Therapeutics soars on debt talk
Shares in hayfever specialist Allergy Therapeutics soar 39 percent on talk that the company is poised to announce a renegotiation of its debt.
STOCKS NEWS UK SMALL-Allergy Therapeutics soars on debt talk
STOCKS NEWS Reuters Results diary
UPDATE 1-Allergy Therapeutics signs Canada deal
* Signed with privately held Nycomed for older Pollinex R
STOCKS NEWS EUROPE-FTSE Small Caps down 1.8 percent at the close
STOCKS NEWS Reuters Results diary
STOCKS NEWS EUROPE-Corporate, economic data diaries thin on Mon
STOCKS NEWS Reuters Results diary





